Less Ads, More Data, More Tools Register for FREE

Pin to quick picksC4XD.L Share News (C4XD)

  • There is currently no data for C4XD

C4XD.L News

C4X promotes Nick Ray to chief scientific officer
10 Jan 2023

C4X promotes Nick Ray to chief scientific officer

(Sharecast News) - Drug discovery company C4X announced the appointment of Nick Ray as its chief scientific officer on Tuesday, with immediate effect.

C4X Discovery promotes Nick Ray to chief scientific officer
10 Jan 2023

C4X Discovery promotes Nick Ray to chief scientific officer

(Alliance News) - C4X Discovery Holdings PLC on Tuesday said it appointed a new scientific officer, promoting internally.

C4X Holdings loss widens; outlook strong amid AstraZeneca partnership
15 Dec 2022

C4X Holdings loss widens; outlook strong amid AstraZeneca partnership

(Alliance News) - C4X Discovery Holdings PLC on Thursday said its annual loss widened, but it remains positive in its outlook, citing a partner progra...

C4X Discovery signs up-to-$402m deal with AstraZeneca
28 Nov 2022

C4X Discovery signs up-to-$402m deal with AstraZeneca

(Sharecast News) - Drug discovery specialist C4X has signed an exclusive worldwide licensing agreement with AstraZeneca worth up to $402m, it announce...

LONDON MARKET MIDDAY: Global equities shaken by civil unrest in China
28 Nov 2022

LONDON MARKET MIDDAY: Global equities shaken by civil unrest in China

(Alliance News) - Stock prices in London were in the red on Monday, as protests across China against its strict Covid policies undermined global risk ...

AIM WINNERS & LOSERS: C4X shares jump on agreement with AstraZeneca
28 Nov 2022

AIM WINNERS & LOSERS: C4X shares jump on agreement with AstraZeneca

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Monday.

C4X Discovery shares up as signs USD400 million deal with AstraZeneca
28 Nov 2022

C4X Discovery shares up as signs USD400 million deal with AstraZeneca

(Alliance News) - C4X Discovery Holdings PLC on Monday said it signed an exclusive worldwide licensing agreement with AstraZeneca PLC for its NRF2 Act...